Levin, F. R., Mariani, J. J., Pavlicova, M., Choi, C. J., Basaraba, C., Mahony, A. L., Brooks, D. J., Brezing, C. A., & Naqvi, N. (2024). Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial. Journal of Attention Disorders, 28(11), 1467–1481. https://doi.org/10.1177/10870547241264675

Mauro, P. M., Gutkind, S., Askari, M. S., Hasin, D. S., Samples, H., Mauro, C. M., Annunziato, E. M., Boustead, A. E., & Martins, S. S. (2024). Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004–2019. Drug and Alcohol Dependence, 257, 111113. https://doi.org/10.1016/j.drugalcdep.2024.111113

Kerr, D. C. R., Levy, N. S., Bae, H., Boustead, A. E., & Martins, S. S. (2023). Cannabis and Alcohol Use by U.S. Young Adults, 2008–2019: Changes in Prevalence After Recreational Cannabis Legalization. American Journal of Preventive Medicine, 65(6), 983–992. https://doi.org/10.1016/j.amepre.2023.06.009

Livne, O., Malte, C. A., Olfson, M., Wall, M. M., Keyes, K. M., Maynard, C., Gradus, J. L., Saxon, A. J., Martins, S. S., Keyhani, S., McDowell, Y., Fink, D. S., Mannes, Z. L., Gutkind, S., & Hasin, D. S. (2024). Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019. American Journal of Psychiatry, 181(2), 144–152. https://doi.org/10.1176/appi.ajp.20230168

Hasin, D. S., Wall, M. M., Alschuler, D. M., Mannes, Z. L., Malte, C., Olfson, M., Keyes, K. M., Gradus, J. L., Cerdá, M., Maynard, C. C., Keyhani, S., Martins, S. S., Fink, D. S., Livne, O., McDowell, Y., Sherman, S., & Saxon, A. J. (2023). Chronic pain, cannabis legalisation, and cannabis use disorder among patients in the US Veterans Health Administration system, 2005 to 2019: a repeated, cross-sectional study. The Lancet Psychiatry, 10(11), 877–886. https://doi.org/10.1016/s2215-0366(23)00268-7

Struble, C. A., Borodovsky, J. T., Habib, M. I., Livne, O., Walsh, C. A., Aharonovich, E., Hasin, D. S., & Budney, A. J. (2024). Evaluating age-related disparities in cannabis-related problems among LGBT+ versus non-LGBT+ adults. Addictive Behaviors, 148, 107861. https://doi.org/10.1016/j.addbeh.2023.107861

Mannes, Z. L., Malte, C. A., Olfson, M., Wall, M. M., Keyes, K. M., Martins, S. S., Cerdá, M., Gradus, J. L., Saxon, A. J., Keyhani, S., Maynard, C., Livne, O., Fink, D. S., Gutkind, S., & Hasin, D. S. (2023). Increasing risk of cannabis use disorder among U.S. veterans with chronic pain: 2005-2019. Pain, 164(9), 2093–2103. https://doi.org/10.1097/j.pain.0000000000002920

Shmulewitz, D., Budney, A. J., Borodovsky, J. T., Bujno, J. M., Walsh, C. A., Struble, C. A., Livne, O., Habib, M. I., Aharonovich, E., & Hasin, D. S. (2023). Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use. Journal of Psychiatric Research, 163, 211–221. https://doi.org/10.1016/j.jpsychires.2023.05.048

Brown, Q. L., Shmulewitz, D., Sarvet, A. L., Young-Wolff, K. C., Howard, T., & Hasin, D. S. (2023). Cannabis use, cannabis use disorder and mental health disorders among pregnant and postpartum women in the US: A nationally representative study. Drug and Alcohol Dependence, 248, 109940. https://doi.org/10.1016/j.drugalcdep.2023.109940

Haney, M., Vallée, M., Fabre, S., Collins Reed, S., Zanese, M., Campistron, G., Arout, C. A., Foltin, R. W., Cooper, Z. D., Kearney-Ramos, T., Metna, M., Justinova, Z., Schindler, C., Hebert-Chatelain, E., Bellocchio, L., Cathala, A., Bari, A., Serrat, R., Finlay, D. B., … Piazza, P. V. (2023). Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials. Nature Medicine, 29(6), 1487–1499. https://doi.org/10.1038/s41591-023-02381-w

Sultan, R. S., Zhang, A. W., Olfson, M., Kwizera, M. H., & Levin, F. R. (2023). Nondisordered Cannabis Use Among US Adolescents. JAMA Network Open, 6(5), e2311294. https://doi.org/10.1001/jamanetworkopen.2023.11294

Gutkind, S., Shmulewitz, D., & Hasin, D. (2023). Sex differences in Cannabis use disorder and associated psychosocial problems among US adults, 2012–2013. Preventive Medicine, 168, 107422. https://doi.org/10.1016/j.ypmed.2023.107422

Logue, T. C., Wen, T., & Friedman, A. M. (2022). Demographic trends associated with substance use disorder and risk for adverse obstetric outcomes with cannabis and opioid use disorders. The Journal of Maternal-Fetal & Neonatal Medicine, 35(26). https://doi.org/10.1080/14767058.2022.2128658

Ibarra‐Lecue, I., Unzueta‐Larrinaga, P., Barrena‐Barbadillo, R., Villate, A., Horrillo, I., Mendivil, B., Landabaso, M. A., Meana, J. J., Etxebarria, N., Callado, L. F., & Urigüen, L. (2022). Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients. Addiction Biology, 27(6). Portico. https://doi.org/10.1111/adb.13233

Fink, D. S., Shmulewitz, D., Mannes, Z. L., Stohl, M., Livne, O., Wall, M., & Hasin, D. S. (2022). Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use. Journal of Psychiatric Research, 155, 387–394. https://doi.org/10.1016/j.jpsychires.2022.09.016

Hasin, D. S., Saxon, A. J., Malte, C., Olfson, M., Keyes, K. M., Gradus, J. L., Cerdá, M., Maynard, C. C., Keyhani, S., Martins, S. S., Fink, D. S., Livne, O., Mannes, Z., & Wall, M. M. (2022). Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005–2019. American Journal of Psychiatry, 179(10), 748–757. https://doi.org/10.1176/appi.ajp.22010034

Mauro, P. M., Gutkind, S., Rivera-Aguirre, A., Gary, D., Cerda, M., Santos, E. C., Castillo-Carniglia, A., & Martins, S. S. (2022). Trends in cannabis or cocaine-related dependence and alcohol/drug treatment in Argentina, Chile, and Uruguay. International Journal of Drug Policy, 108, 103810. https://doi.org/10.1016/j.drugpo.2022.103810

Hernandez, M., & Levin, F. R. (2022). Attention-Deficit Hyperactivity Disorder and Therapeutic Cannabis Use Motives. Psychiatric Clinics of North America, 45(3), 503–514. https://doi.org/10.1016/j.psc.2022.05.010

Haney, M., Bedi, G., Cooper, Z. D., Herrmann, E. S., Reed, S. C., Foltin, R. W., Kingsley, P. J., Marnett, L. J., & Patel, S. (2022). Impact of cyclooxygenase‐2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers. Addiction Biology, 27(4). Portico. https://doi.org/10.1111/adb.13183